Repligen Corporation
RGEN
$130.13
$4.803.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 194.26M | 197.91M | 188.81M | 182.37M | 169.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 194.26M | 197.91M | 188.81M | 182.37M | 169.17M |
| Cost of Revenue | 85.97M | 94.08M | 88.29M | 89.37M | 77.80M |
| Gross Profit | 108.28M | 103.83M | 100.52M | 93.00M | 91.37M |
| SG&A Expenses | 76.54M | 74.36M | 73.66M | 69.41M | 70.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 176.97M | 181.57M | 176.13M | 172.75M | 160.62M |
| Operating Income | 17.29M | 16.35M | 12.68M | 9.62M | 8.55M |
| Income Before Tax | 1.77M | 19.11M | 17.11M | 18.22M | 7.94M |
| Income Tax Expenses | -6.56M | 5.83M | 2.20M | 3.35M | 2.11M |
| Earnings from Continuing Operations | 8.33M | 13.29M | 14.91M | 14.87M | 5.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.33M | 13.29M | 14.91M | 14.87M | 5.83M |
| EBIT | 17.29M | 16.35M | 12.68M | 9.62M | 8.55M |
| EBITDA | 37.05M | 36.30M | 32.69M | 29.70M | 27.26M |
| EPS Basic | 0.15 | 0.24 | 0.27 | 0.26 | 0.10 |
| Normalized Basic EPS | 0.19 | 0.20 | 0.14 | 0.15 | 0.11 |
| EPS Diluted | 0.15 | 0.23 | 0.26 | 0.26 | 0.10 |
| Normalized Diluted EPS | 0.19 | 0.19 | 0.14 | 0.15 | 0.11 |
| Average Basic Shares Outstanding | 56.35M | 56.31M | 56.27M | 56.23M | 56.12M |
| Average Diluted Shares Outstanding | 56.67M | 56.66M | 56.53M | 56.51M | 56.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |